Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2C19 | P33261 | 1/20 | 0.52 |
| ▸ | TSHR | P16473 | 2/20 | 0.46 |
| ▸ | ACHE | P22303 | 2/20 | 0.46 |
| ▸ | LMNA | P02545 | 2/20 | 0.46 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.44 |
| ▸ | CA12 | O43570 | 1/20 | 0.42 |
| ▸ | CA9 | Q16790 | 1/20 | 0.42 |
| ▸ | HPGD | P15428 | 1/20 | 0.39 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.38 |
| ▸ | TRPM8 | Q7Z2W7 | 1/20 | 0.38 |
| ▸ | NR3C2 | P08235 | 1/20 | 0.38 |
| ▸ | HTT | P42858 | 1/20 | 0.38 |
| ▸ | MEN1 | O00255 | 1/20 | 0.38 |
| ▸ | NPC1 | O15118 | 1/20 | 0.38 |
| ▸ | RAB9A | P51151 | 1/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.38 |
| ▸ | CNR2 | P34972 | 2/20 | 0.37 |
| ▸ | CNR1 | P21554 | 1/20 | 0.37 |
| ▸ | TP53 | P04637 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14962874 | 1.00 | CYP2C19 (0.52) | CYP2C19TSHRACHELMNAALOX12 | |
| SCHEMBL14203430 | 0.88 | CYP2C19 (0.43) | CYP2C19TSHRACHELMNAALOX12 | |
| SCHEMBL1304312 | 0.84 | KCNH2 (0.41) | CYP2C19TSHRALDH1A1TDP1HTT | |
| SCHEMBL5609630 | 0.84 | NR3C2 (0.53) | CYP2C19TSHRACHELMNAALOX12 | |
| SCHEMBL10153572 | 0.80 | CYP2C19 (0.62) | CYP2C19TSHRLMNAALDH1A1NR3C2 | |
| SCHEMBL9446198 | 0.80 | CYP2C19 (0.68) | CYP2C19TSHRLMNAALDH1A1NR3C2 | |
| SCHEMBL12763844 | 0.80 | CYP2C19 (0.62) | CYP2C19TSHRLMNAALDH1A1NR3C2 | |
| SCHEMBL21146865 | 0.80 | NR3C2 (0.50) | CYP2C19TSHRACHELMNAALOX12 | |
| SCHEMBL14258202 | 0.80 | ALDH1A1 (0.54) | CYP2C19TSHRALDH1A1TDP1NR3C2 | |
| SCHEMBL11697232 | 0.79 | KDM4E (0.49) | CYP2C19TSHRACHELMNAALOX12 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9331284-B2 | Polymer compound and light-emitting device using same | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2016-05-03 | — | — | US | disclosed |
| US-9269905-B2 | Polymer compound having carbon cluster structure and organic device using same | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2016-02-23 | — | — | US | disclosed |
| US-20130270545-A1 | POLYMER COMPOUND HAVING CARBON CLUSTER STRUCTURE AND ORGANIC DEVICE USING SAME | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2013-10-17 | — | — | US | disclosed |
| US-20120326140-A1 | POLYMER COMPOUND AND LIGHT-EMITTING DEVICE USING SAME | CAMBRIDGE DISPLAY TECHNOLOGY LIMITED (GB) | 2012-12-27 | — | — | US | disclosed |
| US-20110187266-A1 | POLYMER COMPOUND AND LIGHT EMITTING DEVICE USING THE SAME | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2011-08-04 | — | — | US | disclosed |
| US-7651746-B2 | Halogenated bisdiarylaminopolycyclic aromatic compounds and polymers thereof | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2010-01-26 | — | — | US | disclosed |
| US-7351788-B2 | Polymer containing substituted triphenylamine units | CAMBRIDGE DISPLAY TECHNOLOGY LIMITED (GB) | 2008-04-01 | — | — | US | disclosed |
| US-20070126345-A1 | Halogenated bisdiarylaminopolycylic aromatic compounds and polymers thereof | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2007-06-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120326140-A1 | POLYMER COMPOUND AND LIGHT-EMITTING DEVICE USING SAME | CCNA1, CCNB1, CCNL2 | CYP2C19 634/4885TSHR 2469/4885ACHE 2098/4885 |
| US-20070126345-A1 | Halogenated bisdiarylaminopolycylic aromatic compounds and polymers thereof | AHR, AADAC, ARNT | CYP2C19 333/4885TSHR 2262/4885ACHE 4213/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.